Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Equifax (EFX) Financials

Equifax logo
$164.01 +0.91 (+0.56%)
As of 03:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Equifax

Annual Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 429 489 587 311 -384 520 744 696 545 604 660
Consolidated Net Income / (Loss)		 435 495 598 317 -378 526 749 700 552 607 664
Net Income / (Loss) Continuing Operations		 435 495 598 317 -378 526 749 700 552 607 664
Total Pre-Tax Income 		637 728 747 370 -414 685 949 930 718 811 895
Total Revenue		 2,600 -92 3,269 3,309 3,396 -142 4,778 4,939 5,024 5,452 5,862
Net Interest Income / (Expense)		 -64 -92 -93 -104 -112 -142 -146 -183 -241 -229 -212
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 64 92 93 104 112 142 146 183 241 229 212
Long-Term Debt Interest Expense		 64 92 93 104 112 142 146 183 241 229 212
Total Non-Interest Income		 2,664 0.00 3,362 3,412 3,508 0.00 4,924 5,122 5,265 5,681 6,075
Other Non-Interest Income		 2,664 - 3,362 3,412 3,508 - 4,924 5,122 5,265 5,681 6,075
Total Non-Interest Expense		 1,970 -820 2,531 2,964 3,843 -827 3,786 4,066 4,332 4,639 4,979
Property & Liability Insurance Claims		 - - 1,211 - 1,522 - 1,981 2,177 2,335 2,519 2,646
Other Operating Expenses		 1,772 2,054 1,032 2,654 1,990 3,060 1,325 1,329 1,386 1,451 1,614
Depreciation Expense		 198 265 288 310 331 391 480 560 611 670 720
Nonoperating Income / (Expense), net		 6.50 - 7.70 26 33 - -43 57 26 -2.50 12
Income Tax Expense		 202 233 149 53 -36 159 201 230 166 203 231
Net Income / (Loss) Attributable to Noncontrolling Interest		 5.70 6.30 11 6.50 6.00 6.10 4.30 4.00 6.40 3.20 4.00
Basic Earnings per Share		 $3.61 $4.10 $4.89 $2.58 ($3.18) $4.28 $6.11 $5.69 $4.44 $4.88 $5.36
Weighted Average Basic Shares Outstanding		 118.70M 119.30M 120.10M 120.40M 120.90M 121.50M 121.90M 122.40M 122.90M 123.80M 123.20M
Diluted Earnings per Share		 $3.55 $4.04 $4.83 $2.56 ($3.15) $4.24 $6.02 $5.65 $4.40 $4.84 $5.32
Weighted Average Diluted Shares Outstanding		 120.90M 121.10M 121.50M 121.40M 122M 122.80M 123.60M 123.30M 123.90M 124.90M 124.10M
Weighted Average Basic & Diluted Shares Outstanding		 118.90M 119.20M 120.10M 120.40M 120.80M 121.79M 122.08M 122.49M 123.96M 124.02M 120.27M
Cash Dividends to Common per Share		 $1.16 $1.32 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.89

Quarterly Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 162 132 125 164 141 174 133 191 160 176 172
Consolidated Net Income / (Loss)		 164 135 126 165 143 173 134 193 162 176 173
Net Income / (Loss) Continuing Operations		 164 135 126 165 143 173 134 193 162 176 173
Total Pre-Tax Income 		191 183 167 225 194 226 185 261 215 233 236
Total Revenue		 1,256 1,266 1,330 1,373 1,386 1,364 1,389 1,484 1,493 1,497 1,593
Net Interest Income / (Expense)		 -63 -60 -60 -57 -56 -56 -53 -53 -52 -54 -56
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 63 60 60 57 56 56 53 53 52 54 56
Long-Term Debt Interest Expense		 63 60 60 57 56 56 53 53 52 54 56
Total Non-Interest Income		 1,319 1,327 1,389 1,431 1,442 1,419 1,442 1,537 1,545 1,551 1,649
Other Non-Interest Income		 1,319 1,327 1,389 1,431 1,442 1,419 1,442 1,537 1,545 1,551 1,649
Total Non-Interest Expense		 1,073 1,082 1,165 1,148 1,195 1,131 1,206 1,226 1,281 1,266 1,361
Property & Liability Insurance Claims		 585 - 628 631 645 - 657 665 663 661 767
Other Operating Expenses		 333 -245 373 353 380 -286 375 384 434 421 411
Depreciation Expense		 154 157 164 165 169 172 175 177 183 184 183
Nonoperating Income / (Expense), net		 7.10 -1.70 1.60 -0.30 3.00 -6.80 2.50 3.60 3.20 2.70 3.80
Income Tax Expense		 26 48 41 59 51 52 52 69 54 57 63
Net Income / (Loss) Attributable to Noncontrolling Interest		 2.10 2.10 1.20 1.30 1.40 -0.70 0.70 1.30 1.30 0.70 1.80
Basic Earnings per Share		 $1.32 $1.07 $1.01 $1.32 $1.14 $1.41 $1.07 $1.54 $1.30 $1.45 $1.43
Weighted Average Basic Shares Outstanding		 123M 122.90M 123.50M 123.70M 123.90M 123.80M 124.10M 124M 123.10M 123.20M 120M
Diluted Earnings per Share		 $1.31 $1.06 $1.00 $1.31 $1.13 $1.40 $1.06 $1.53 $1.29 $1.44 $1.42
Weighted Average Diluted Shares Outstanding		 123.90M 123.90M 124.80M 124.80M 125.20M 124.90M 125.10M 125M 124.10M 124.10M 120.80M
Weighted Average Basic & Diluted Shares Outstanding		 123.22M 123.96M 123.61M 123.74M 123.95M 124.02M 124.20M 123.80M 122.39M 120.27M 119.07M
Cash Dividends to Common per Share		 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.50 $0.50 $0.50 $0.56

Annual Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -35 36 207 -113 178 1,283 -1,460 61 -68 -47 11
Net Cash From Operating Activities		 769 823 816 672 314 946 1,335 757 1,117 1,325 1,616
Net Cash From Continuing Operating Activities		 769 823 816 672 314 946 1,335 757 1,117 1,325 1,616
Net Income / (Loss) Continuing Operations		 435 495 598 317 -378 526 749 700 552 607 664
Consolidated Net Income / (Loss)		 435 495 598 317 -378 526 749 700 552 607 664
Depreciation Expense		 200 269 291 316 337 399 490 569 620 681 727
Non-Cash Adjustments to Reconcile Net Income		 -5.50 -12 -5.80 43 -33 -28 123 114 -12 15 107
Changes in Operating Assets and Liabilities, net		 140 71 -67 -3.20 388 49 -26 -626 -43 22 117
Net Cash From Investing Activities		 -148 -1,976 -350 -462 -698 -493 -3,398 -960 -878 -512 -554
Net Cash From Continuing Investing Activities		 -148 -1,976 -350 -462 -698 -493 -3,398 -960 -878 -512 -554
Purchase of Investment Securities		 -151 -1,976 -358 -6.90 -698 -493 -3,405 -1,058 -885 -512 -556
Divestitures		 2.90 - - - 0.00 0.00 1.50 99 6.90 0.00 1.20
Net Cash From Financing Activities		 -639 1,160 -264 -311 558 811 618 274 -306 -846 -1,060
Net Cash From Continuing Financing Activities		 -639 1,160 -264 -311 558 811 618 274 -306 -846 -1,060
Issuance of Debt		 0.00 1,575 352 995 998 1,123 1,697 992 873 650 1.70
Repayment of Debt		 -336 -283 -323 -1,067 -257 -136 -791 -506 -957 -1,360 75
Repurchase of Common Equity		 -196 0.00 -77 - 0.00 0.00 -70 - 0.00 0.00 -928
Payment of Dividends		 -144 -163 -196 -198 -195 -194 -197 -194 -237 -198 -239
Other Financing Activities, Net		 37 32 -20 -40 12 17 -22 -17 15 61 31
Effect of Exchange Rate Changes		 -17 29 4.30 -13 3.50 19 -14 -11 -0.80 -14 9.20

Quarterly Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 249 -196 -16 -19 286 -298 25 -6.20 - -8.20 2.60
Net Cash From Operating Activities		 382 322 253 268 480 325 224 361 560 471 242
Net Cash From Continuing Operating Activities		 382 328 253 268 480 325 224 361 560 471 242
Net Income / (Loss) Continuing Operations		 164 135 126 165 143 173 134 193 162 176 173
Consolidated Net Income / (Loss)		 164 135 126 165 143 173 134 193 162 176 173
Depreciation Expense		 157 159 167 167 173 174 176 179 185 186 185
Non-Cash Adjustments to Reconcile Net Income		 -53 8.20 23 -2.60 6.00 -12 31 8.00 54 15 57
Changes in Operating Assets and Liabilities, net		 114 27 -63 -62 157 -10 -117 -19 159 94 -173
Net Cash From Investing Activities		 -406 -154 -132 -137 -124 -119 -107 -121 -122 -204 -120
Net Cash From Continuing Investing Activities		 -406 -154 -132 -137 -124 -119 -107 -121 -122 -204 -120
Purchase of Investment Securities		 -406 448 -132 -137 -124 -119 -107 -122 -122 -204 -120
Net Cash From Financing Activities		 281 -370 -132 -149 -64 -501 -96 -251 -437 -276 -118
Net Cash From Continuing Financing Activities		 281 -370 -132 -149 -64 -501 -96 -251 -437 -276 -118
Issuance of Debt		 - - - - 650 - -48 - - - 215
Repayment of Debt		 327 -292 -88 -115 -694 -463 0.00 -68 -88 279 -1.40
Repurchase of Common Equity		 - - - - - - 0.00 - -300 -500 -260
Payment of Dividends		 -49 -91 -49 -51 -49 -49 -49 -66 -64 -61 -67
Other Financing Activities, Net		 2.10 13 4.50 18 29 10 0.80 10 13 6.00 -4.10
Effect of Exchange Rate Changes		 -7.90 5.30 -4.70 -1.10 -4.90 -2.80 4.40 5.10 -1.20 0.90 -1.20

Annual Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 4,502 6,664 7,233 7,153 7,909 9,612 11,041 11,548 12,280 11,759 11,864
Cash and Due from Banks		 93 129 336 224 401 1,685 225 285 217 170 181
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 154 160 139 81 948 -235 1,316 1,587 1,834 1,892 -1,166
Goodwill		 2,571 3,974 4,184 4,130 4,308 4,496 6,258 6,384 6,830 6,548 6,746
Intangible Assets		 1,135 1,726 1,770 1,878 1,140 2,467 1,993 1,913 1,954 1,616 4,524
Other Assets		 548 675 804 841 1,112 1,199 1,249 1,379 1,446 1,534 1,579
Total Liabilities & Shareholders' Equity		 4,502 6,664 7,233 7,153 7,909 9,612 11,041 11,548 12,280 11,759 11,864
Total Liabilities		 2,151 3,943 3,994 3,998 5,286 6,402 7,440 7,575 7,593 6,840 7,126
Short-Term Debt		 90 666 1,076 181 151 1,260 1,036 1,218 1,161 826 1,244
Accrued Interest Payable		 113 149 161 213 164 252 238 229 245 251 276
Other Short-Term Payables		 401 444 329 433 1,044 971 1,017 568 613 735 815
Long-Term Debt		 1,138 2,087 1,739 2,631 3,380 3,277 4,470 4,820 4,748 4,674 4,055
Other Long-Term Liabilities		 409 596 690 540 548 641 678 739 826 354 735
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - - - - - - - 0.00 135 105 114
Total Equity & Noncontrolling Interests		 2,350 2,721 3,239 3,156 2,623 3,210 3,601 3,973 4,552 4,814 4,624
Total Preferred & Common Equity		 2,311 2,663 3,174 3,108 2,579 3,168 3,584 3,957 4,534 4,797 4,604
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2,311 2,663 3,174 3,108 2,579 3,168 3,584 3,957 4,534 4,797 4,604
Common Stock		 1,491 1,544 1,563 1,587 1,636 1,701 1,767 1,825 1,992 2,146 2,254
Retained Earnings		 3,834 4,153 4,601 4,718 3,855 4,185 4,752 5,256 5,609 6,019 6,445
Treasury Stock		 -2,530 -2,506 -2,578 -2,571 -2,557 -2,547 -2,639 -2,651 -2,635 -2,645 -3,578
Accumulated Other Comprehensive Income / (Loss)		 -485 -529 -412 -626 -354 -171 -295 -474 -431 -723 -517
Noncontrolling Interest		 40 59 65 48 44 42 17 17 18 18 20

Quarterly Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 11,538 12,349 12,280 12,251 12,152 12,344 11,759 11,855 11,918 11,832 11,942
Cash and Due from Banks		 164 413 217 201 182 468 170 195 189 189 183
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 -629 -665 1,834 -746 -813 -874 1,892 -974 -1,017 -1,087 -1,059
Goodwill		 6,401 6,731 6,830 6,761 6,747 6,730 6,548 6,591 6,655 6,665 6,791
Intangible Assets		 4,145 4,427 1,954 4,464 4,483 4,517 1,616 4,432 4,450 4,467 4,366
Other Assets		 1,457 1,443 1,446 1,571 1,554 1,503 1,534 1,611 1,641 1,598 1,660
Total Liabilities & Shareholders' Equity		 11,538 12,349 12,280 12,251 12,152 12,344 11,759 11,855 11,918 11,832 11,942
Total Liabilities		 7,330 7,864 7,593 7,539 7,319 7,298 6,840 6,742 6,682 6,756 7,259
Short-Term Debt		 317 692 1,161 1,078 972 903 826 812 1,019 916 1,411
Accrued Interest Payable		 271 267 245 306 238 263 251 281 270 299 379
Other Short-Term Payables		 504 623 613 590 577 708 735 638 657 769 661
Long-Term Debt		 5,503 5,500 4,748 4,745 4,743 4,721 4,323 4,324 4,051 4,054 4,056
Other Long-Term Liabilities		 734 782 826 820 789 702 706 687 686 719 753
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - 176 135 132 121 121 105 113 116 119 120
Total Equity & Noncontrolling Interests		 4,208 4,309 4,552 4,581 4,713 4,926 4,814 5,000 5,120 4,957 4,562
Total Preferred & Common Equity		 4,191 4,293 4,534 4,562 4,696 4,909 4,797 4,981 5,104 4,939 4,541
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 4,191 4,293 4,534 4,562 4,696 4,909 4,797 4,981 5,104 4,939 4,541
Common Stock		 1,881 1,967 1,992 2,055 2,088 2,128 2,146 2,184 2,206 2,234 2,295
Retained Earnings		 5,411 5,525 5,609 5,685 5,800 5,893 6,019 6,103 6,232 6,330 6,549
Treasury Stock		 -2,655 -2,635 -2,635 -2,652 -2,648 -2,647 -2,645 -2,648 -2,775 -3,074 -3,841
Accumulated Other Comprehensive Income / (Loss)		 -446 -564 -431 -527 -544 -465 -723 -657 -560 -551 -462
Noncontrolling Interest		 17 16 18 19 17 17 18 19 16 19 22

Annual Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $3.61 $4.10 $4.89 $2.49 ($3.30) $4.28 $6.11 $5.69 $4.44 $4.88 $5.36
Adjusted Weighted Average Basic Shares Outstanding		 118.70M 119.30M 120.10M 120.40M 120.90M 121.50M 121.90M 122.40M 122.90M 123.80M 123.20M
Adjusted Diluted Earnings per Share		 $3.55 $4.04 $4.83 $2.47 ($3.27) $4.24 $6.02 $5.65 $4.40 $4.84 $5.32
Adjusted Weighted Average Diluted Shares Outstanding		 120.90M 121.10M 121.50M 121.40M 122M 122.80M 123.60M 123.30M 123.90M 124.90M 124.10M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($3.30) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 118.71M 119.85M 120.12M 120.70M 121.24M 121.79M 122.08M 122.49M 123.96M 124.02M 120.27M
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 120,269,998.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 120,269,998.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 1.44
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 4.94% 10.74% 6.85% 9.25% 10.28% 7.69% 4.47% 8.06% 7.74% - 14.69%
EBITDA Growth		 0.47% 29.10% 10.53% 19.34% 7.02% 18.23% 8.35% 11.54% 9.06% - 16.00%
EBIT Growth		 -6.23% 51.93% 11.64% 27.64% 3.92% 25.84% 10.85% 14.58% 11.16% - 26.85%
NOPAT Growth		 6.35% 44.81% 13.31% 29.37% -11.18% 31.51% 5.69% 14.83% 13.25% - 29.18%
Net Income Growth		 -1.56% 23.28% 11.10% 18.51% -13.15% 28.85% 6.11% 16.59% 13.17% - 29.52%
EPS Growth		 -2.24% 20.45% 9.89% 16.96% -13.74% 32.08% 6.00% 16.79% 14.16% - 33.96%
Operating Cash Flow Growth		 7.55% -1.01% 67.46% 2.06% 25.62% 0.84% -11.40% 34.99% 16.77% - 8.04%
Free Cash Flow Firm Growth		 -48.18% 44.55% -448.00% -73.17% 121.25% 257.30% 210.44% 222.10% 436.97% - -35.49%
Invested Capital Growth		 8.61% 5.84% 5.02% 5.18% -0.05% -4.98% -2.72% -2.29% -5.87% - -0.97%
Revenue Q/Q Growth		 -0.05% 0.79% 5.02% 3.27% 0.90% -1.58% 1.87% 6.82% 0.59% - 6.46%
EBITDA Q/Q Growth		 3.66% 0.91% -3.44% 18.15% -7.04% 11.48% -11.50% 21.63% -9.11% - 0.12%
EBIT Q/Q Growth		 4.20% 0.54% -10.62% 36.30% -15.16% 21.75% -21.27% 40.90% -17.70% - 0.78%
NOPAT Q/Q Growth		 23.71% -14.18% -8.00% 32.45% -15.07% 27.07% -26.06% 43.90% -16.24% - -2.21%
Net Income Q/Q Growth		 17.86% -18.14% -6.25% 31.01% -13.62% 21.44% -22.79% 43.95% -16.15% - -1.76%
EPS Q/Q Growth		 16.96% -19.08% -5.66% 31.00% -13.74% 23.89% -24.29% 44.34% -15.69% - -1.39%
Operating Cash Flow Q/Q Growth		 45.63% -15.61% -21.55% 5.86% 79.25% -32.26% -31.07% 61.28% 55.05% - -48.62%
Free Cash Flow Firm Q/Q Growth		 -236.82% 34.71% 15.59% 6.71% 141.33% 383.29% -40.74% 3.14% 81.78% - -51.45%
Invested Capital Q/Q Growth		 6.46% -0.75% -0.57% 0.12% 1.17% -5.65% 1.79% 0.56% -2.53% - 1.11%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 27.09% 27.12% 24.94% 28.53% 26.29% 29.77% 25.87% 29.45% 26.61% - 26.16%
EBIT Margin		 14.61% 14.58% 12.41% 16.38% 13.77% 17.04% 13.17% 17.37% 14.21% - 14.56%
Profit (Net Income) Margin		 13.08% 10.62% 9.48% 12.03% 10.30% 12.71% 9.63% 12.98% 10.82% - 10.88%
Tax Burden Percent		 86.16% 73.54% 75.69% 73.55% 73.63% 76.85% 72.17% 73.71% 75.01% - 73.49%
Interest Burden Percent		 103.87% 99.08% 100.97% 99.87% 101.57% 97.07% 101.37% 101.40% 101.51% - 101.64%
Effective Tax Rate		 13.84% 26.46% 24.31% 26.45% 26.37% 23.15% 27.83% 26.29% 24.99% - 26.51%
Return on Invested Capital (ROIC)		 6.02% 5.23% 4.67% 6.12% 5.09% 6.91% 5.04% 6.90% 5.90% - 6.37%
ROIC Less NNEP Spread (ROIC-NNEP)		 6.12% 5.21% 4.69% 6.11% 5.12% 6.81% 5.07% 6.95% 5.94% - 6.42%
Return on Net Nonoperating Assets (RNNOA)		 9.07% 7.18% 6.27% 7.80% 6.35% 7.84% 5.66% 7.44% 6.22% - 6.95%
Return on Equity (ROE)		 15.09% 12.41% 10.94% 13.92% 11.44% 14.75% 10.70% 14.35% 12.11% - 13.31%
Cash Return on Invested Capital (CROIC)		 -3.48% -0.51% 0.41% 0.64% 5.36% 11.01% 8.69% 8.46% 12.41% - 7.78%
Operating Return on Assets (OROA)		 6.06% 6.15% 5.32% 7.23% 5.97% 7.73% 6.02% 8.11% 6.73% - 7.42%
Return on Assets (ROA)		 5.42% 4.48% 4.07% 5.31% 4.47% 5.76% 4.40% 6.06% 5.13% - 5.55%
Return on Common Equity (ROCE)		 14.71% 12.17% 10.73% 13.68% 11.04% 14.33% 10.39% 13.96% 11.78% - 12.94%
Return on Equity Simple (ROE_SIMPLE)		 12.26% 0.00% 12.37% 12.57% 11.58% 0.00% 12.35% 12.59% 13.39% - 15.50%
Net Operating Profit after Tax (NOPAT)		 158 136 125 165 140 179 132 190 159 - 171
NOPAT Margin		 12.59% 10.72% 9.39% 12.05% 10.14% 13.09% 9.50% 12.80% 10.66% - 10.70%
Net Nonoperating Expense Percent (NNEP)		 -0.10% 0.02% -0.02% 0.00% -0.04% 0.09% -0.03% -0.05% -0.05% - -0.05%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue		 85.39% 85.42% 87.59% 83.62% 86.23% 82.96% 86.83% 82.63% 85.79% - 85.44%
Earnings before Interest and Taxes (EBIT)		 184 185 165 225 191 232 183 258 212 - 232
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 340 343 332 392 364 406 359 437 397 - 417
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.20 6.68 7.21 6.38 7.41 6.59 6.06 6.31 6.43 - 4.77
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)		 4.56 6.03 6.44 5.74 6.79 5.79 5.48 5.73 5.54 - 3.57
Price to Earnings (P/E)		 42.88 55.55 59.00 51.37 64.64 52.29 49.33 50.36 48.22 - 31.00
Dividend Yield		 0.86% 0.63% 0.58% 0.64% 0.53% 0.61% 0.64% 0.64% 0.69% - 1.14%
Earnings Yield		 2.33% 1.80% 1.69% 1.95% 1.55% 1.91% 2.03% 1.99% 2.07% - 3.23%
Enterprise Value to Invested Capital (EV/IC)		 2.65 3.41 3.67 3.38 3.90 3.64 3.44 3.61 3.65 - 2.67
Enterprise Value to Revenue (EV/Rev)		 5.78 7.19 7.57 6.82 7.78 6.73 6.40 6.62 6.40 - 4.46
Enterprise Value to EBITDA (EV/EBITDA)		 22.93 27.54 28.79 25.33 29.11 24.57 23.19 23.76 22.93 - 16.24
Enterprise Value to EBIT (EV/EBIT)		 45.00 52.20 54.53 47.01 54.43 45.13 42.46 43.10 41.44 - 29.06
Enterprise Value to NOPAT (EV/NOPAT)		 57.84 67.93 70.76 60.93 73.52 60.23 57.26 58.10 55.62 - 39.03
Enterprise Value to Operating Cash Flow (EV/OCF)		 25.27 32.36 31.74 29.12 31.51 27.70 27.23 26.80 24.95 - 16.58
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 906.91 541.40 72.79 32.26 39.07 42.18 28.54 - 34.13
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.38 1.26 1.24 1.18 1.11 1.05 1.00 0.97 0.98 - 1.17
Long-Term Debt to Equity		 1.23 1.01 1.01 0.98 0.94 0.88 0.85 0.77 0.80 - 0.87
Financial Leverage		 1.48 1.38 1.34 1.28 1.24 1.15 1.12 1.07 1.05 - 1.08
Leverage Ratio		 2.86 2.75 2.71 2.62 2.59 2.50 2.45 2.39 2.39 - 2.43
Compound Leverage Factor		 2.97 2.73 2.74 2.62 2.63 2.43 2.49 2.42 2.42 - 2.47
Debt to Total Capital		 58.00% 55.76% 55.27% 54.17% 52.71% 51.14% 50.12% 49.20% 49.47% - 53.86%
Short-Term Debt to Total Capital		 6.48% 10.96% 10.23% 9.21% 8.47% 8.20% 7.92% 9.89% 9.11% - 13.90%
Long-Term Debt to Total Capital		 51.52% 44.81% 45.04% 44.96% 44.24% 42.93% 42.19% 39.31% 40.36% - 39.96%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 1.79% 1.45% 1.43% 1.30% 1.29% 1.22% 1.28% 1.28% 1.37% - 1.40%
Common Equity to Total Capital		 40.21% 42.79% 43.30% 44.52% 46.00% 47.64% 48.60% 49.53% 49.16% - 44.74%
Debt to EBITDA		 5.02 4.50 4.33 4.06 3.93 3.45 3.38 3.24 3.11 - 3.28
Net Debt to EBITDA		 4.68 4.34 4.18 3.93 3.60 3.33 3.25 3.12 2.99 - 3.17
Long-Term Debt to EBITDA		 4.46 3.62 3.53 3.37 3.30 2.89 2.84 2.59 2.53 - 2.43
Debt to NOPAT		 12.65 11.11 10.65 9.77 9.93 8.45 8.34 7.91 7.54 - 7.88
Net Debt to NOPAT		 11.81 10.70 10.29 9.46 9.10 8.17 8.02 7.62 7.25 - 7.61
Long-Term Debt to NOPAT		 11.24 8.93 8.68 8.11 8.33 7.10 7.02 6.32 6.15 - 5.84
Noncontrolling Interest Sharing Ratio		 2.52% 1.97% 1.91% 1.71% 3.45% 2.87% 2.86% 2.67% 2.72% - 2.79%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -688 -449 -379 -354 146 707 419 432 785 - 270
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Free Cash Flow to Firm to Interest Expense		 -10.95 -7.45 -6.35 -6.17 2.60 12.66 7.91 8.13 15.04 - 4.85
Operating Cash Flow to Interest Expense		 6.08 5.34 4.23 4.67 8.52 5.82 4.23 6.80 10.73 - 4.34
Operating Cash Flow Less CapEx to Interest Expense		 6.08 5.34 4.23 4.67 8.52 5.82 4.23 6.80 10.73 - 4.34
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.41 0.42 0.43 0.44 0.43 0.45 0.46 0.47 0.47 - 0.51
Fixed Asset Turnover		 0.00 2.94 0.00 0.00 0.00 2.93 0.00 0.00 0.00 - 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 10,677 10,596 10,536 10,548 10,671 10,068 10,249 10,306 10,045 - 10,149
Invested Capital Turnover		 0.48 0.49 0.50 0.51 0.50 0.53 0.53 0.54 0.55 - 0.59
Increase / (Decrease) in Invested Capital		 846 585 504 519 -5.70 -528 -287 -242 -626 - -100
Enterprise Value (EV)		 28,310 36,135 38,683 35,641 41,655 36,691 35,280 37,227 36,675 - 27,082
Market Capitalization		 22,339 30,290 32,910 29,971 36,361 31,589 30,207 32,214 31,758 - 21,657
Book Value per Share		 $34.98 $36.80 $36.94 $37.99 $39.67 $38.70 $40.16 $41.10 $39.89 - $37.75
Tangible Book Value per Share		 ($55.94) ($34.49) ($53.96) ($52.86) ($51.22) ($27.16) ($48.71) ($48.32) ($50.02) - ($55.01)
Total Capital		 10,677 10,596 10,536 10,548 10,671 10,068 10,249 10,306 10,045 - 10,149
Total Debt		 6,192 5,909 5,823 5,714 5,624 5,149 5,136 5,070 4,969 - 5,467
Total Long-Term Debt		 5,500 4,748 4,745 4,743 4,721 4,323 4,324 4,051 4,054 - 4,056
Net Debt		 5,780 5,692 5,622 5,532 5,156 4,979 4,941 4,881 4,780 - 5,283
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Net Nonoperating Expense (NNE)		 -6.12 1.25 -1.21 0.22 -2.21 5.23 -1.80 -2.65 -2.40 - -2.79
Net Nonoperating Obligations (NNO)		 6,192 5,909 5,823 5,714 5,624 5,149 5,136 5,070 4,969 - 5,467
Total Depreciation and Amortization (D&A)		 157 159 167 167 173 174 176 179 185 - 185
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.32 $1.07 $1.01 $1.32 $1.14 $1.41 $1.07 $1.54 $1.30 $1.45 $1.43
Adjusted Weighted Average Basic Shares Outstanding		 123M 122.90M 123.50M 123.70M 123.90M 123.80M 124.10M 124M 123.10M 123.20M 120M
Adjusted Diluted Earnings per Share		 $1.31 $1.06 $1.00 $1.31 $1.13 $1.40 $1.06 $1.53 $1.29 $1.44 $1.42
Adjusted Weighted Average Diluted Shares Outstanding		 123.90M 123.90M 124.80M 124.80M 125.20M 124.90M 125.10M 125M 124.10M 124.10M 120.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 123.22M 123.96M 123.61M 123.74M 123.95M 124.02M 124.20M 123.80M 122.39M 120.27M 119.07M
Normalized Net Operating Profit after Tax (NOPAT)		 158 136 125 165 140 179 132 190 159 - 171
Normalized NOPAT Margin		 12.59% 10.72% 9.39% 12.05% 10.14% 13.09% 9.50% 12.80% 10.66% - 10.70%
Pre Tax Income Margin		 15.18% 14.44% 12.53% 16.36% 13.99% 16.54% 13.35% 17.61% 14.42% - 14.80%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 2.92 3.06 2.76 3.93 3.39 4.16 3.46 4.85 4.06 - 4.17
NOPAT to Interest Expense		 2.52 2.25 2.09 2.89 2.50 3.20 2.50 3.58 3.05 - 3.06
EBIT Less CapEx to Interest Expense		 2.92 3.06 2.76 3.93 3.39 4.16 3.46 4.85 4.06 - 4.17
NOPAT Less CapEx to Interest Expense		 2.52 2.25 2.09 2.89 2.50 3.20 2.50 3.58 3.05 - 3.06
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 37.03% 43.03% 42.19% 40.59% 42.23% 32.57% 32.15% 33.11% 34.30% - 36.59%
Augmented Payout Ratio		 37.03% 43.03% 42.19% 40.59% 42.23% 32.57% 32.15% 33.11% 34.30% - 205.31%

Financials Breakdown Chart

Key Financial Trends

Equifax (EFX) has shown a generally positive trajectory in 2022–2025, with solid revenue, improving profitability, and steady cash flow generation. The latest Q4 2025 data highlight continued top‑line growth, earnings expansion, and a robust balance sheet, though financing activity and high intangible assets are worth watching.

  • Total revenue reached about $1.50B in Q4 2025, up from about $1.33B in Q1 2025, signaling ongoing top‑line growth.
  • Net income from continuing operations rose to $176.4M in Q4 2025, up from $133.8M in Q1 2025, showing improvements in profitability across 2025.
  • Diluted earnings per share climbed to $1.44 in Q4 2025, supported by stronger earnings and stable share counts.
  • Operating cash flow remains robust, with net cash from continuing operating activities around $471M in Q4 2025, contributing to healthy cash generation.
  • Cash dividends per share increased to $0.50 in Q4 2025, signaling a higher cash return to shareholders.
  • The balance sheet shows a solid liquidity position, with total assets around $11.8–11.9B and equity about $4.9–$5.0B; debt levels are manageable (long‑term debt around $4.05B and short‑term debt around $0.92B in mid‑2025 data).
  • Goodwill and intangible assets remain a large portion of assets (Goodwill ≈ $6.6B; Intangible assets ≈ $4.0–$4.5B in 2025), which could pose impairment risk if business conditions worsen.
  • Capital returns include sizable share repurchases in late‑2025 (e.g., about $500M in Q4 2025), which can support per‑share metrics but reduce near‑term cash liquidity.
  • Net change in cash and equivalents was negative in several 2025 quarters, reflecting heavy use of cash for investing and financing activities and potential near‑term liquidity pressure.
05/22/26 03:55 PM ETAI Generated. May Contain Errors.

Equifax Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Equifax's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Equifax's net income appears to be on an upward trend, with a most recent value of $664.30 million in 2025, rising from $434.80 million in 2015. The previous period was $607.30 million in 2024. View Equifax's forecast to see where analysts expect Equifax to go next.

Over the last 10 years, Equifax's total revenue changed from $2.60 billion in 2015 to $5.86 billion in 2025, a change of 125.5%.

Equifax's total liabilities were at $7.13 billion at the end of 2025, a 4.2% increase from 2024, and a 231.3% increase since 2015.

In the past 10 years, Equifax's cash and equivalents has ranged from $93.30 million in 2015 to $1.68 billion in 2020, and is currently $180.80 million as of their latest financial filing in 2025.


Related Companies

Financial statements for NYSE:EFX last updated on 4/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
To Avoid 67 Million Blackouts, Trump Signs Emergency Backing of New Energy Tech
President Trump has used emergency executive powers to back a new energy technology described as 326 times mor...
Altimetry | Sponsoredtc pixel
Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...
InvestorPlace | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel